Heparanase Expression Propagates Liver Damage in CCL4-Induced Mouse Model

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Heparanase is elevated in various pathological conditions, primarily cancer and inflammation. To investigate the significance and involvement of heparanase in liver fibrosis, we compared the susceptibility of wild-type (WT) and heparanase-overexpressing transgenic (Hpa-tg) mice to carbon tetrachloride (CCL4)-induced fibrosis. In comparison with WT mice, Hpa-tg mice displayed a severe degree of tissue damage and fibrosis, including higher necrotic tendency and intensified expression of smooth muscle actin. While damage to the WT liver started to recover after the acute phase, damage to the Hpa-tg liver was persistent. Recovery was attributed, in part, to heparanase-stimulated autophagic activity in response to CCL4, leading to increased apoptosis and necrosis. The total number of stellate cells was significantly higher in the Hpa-tg than the WT liver, likely contributing to the increased amounts of lipid droplets and smooth muscle actin. Our results support the notion that heparanase enhances inflammatory responses, and hence may serve as a target for the treatment of liver damage and fibrosis.
Funding Information
  • National Key Research and Development Program of China (2021YFC2103100, 2021-01094, CAN211417Pj)
  • Vetenskapsrådet (2021YFC2103100, 2021-01094, CAN211417Pj)
  • Swedish Cancer Foundation (2021YFC2103100, 2021-01094, CAN211417Pj)

This publication has 33 references indexed in Scilit: